User Settings
Article10.1007/978-1-60327-323-7_25

Transplantation of Human Mesenchymal Stem Cells in the Study of Neuropathic Pain

Dario Siniscalco-2010-01-01-Methods in molecular biology
14

TL;DRAbstract

Neuropathic pain is a complex disease that involves several molecular pathways. Due to its individual character, the treatment of neuropathic pain is extremely difficult. Currently available drugs do not affect the mechanisms underlying the generation and propagation of pain. Therefore, pain research is now focused on molecular approaches such as stem cell therapy. Stem cells mediate neuroprotection in a variety of nervous system injury models. We used spared nerve injury (SNI) model of neuropathic pain to assess the possible use of human mesenchymal stem cells (hMSCs) as neuroprotective tool in the regenerative medicine. We conclude that stem cell transplantation could be a useful therapeutic tool in the future of regenerative medicine.

Chat with Paper

AI Agents for this Paper

Neuropathic pain is a complex disease that involves several molecular pathways. Due to its individual character, the treatment of neuropathic pain is extremely difficult. Currently available drugs do not affect the mechanisms underlying the generation and propagation of pain. Therefore, pain research is now focused on molecular approaches such as stem cell therapy. Stem cells mediate neuroprotection in a variety of nervous system injury models. We used spared nerve injury (SNI) model of neuropathic pain to assess the possible use of human mesenchymal stem cells (hMSCs) as neuroprotective tool in the regenerative medicine. We conclude that stem cell transplantation could be a useful therapeutic tool in the future of regenerative medicine.

Keywords

Neuropathic painMedicineNeuroprotectionMesenchymal stem cellRegenerative medicineStem cellTransplantationNerve injury

Chat

Click to start Chat